You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
珍寶島(603567.SH):在創新藥領域着重聚焦消化類、抗腫瘤類等治療領域

格隆匯6月13日丨珍寶島(603567.SH)在投資者互動平臺表示,公司在創新藥領域着重聚焦消化類、抗腫瘤類等治療領域。中藥創新藥方面:公司在研1.1類中藥創新藥用於治療非糜爛性胃食管反流病寒熱錯雜、胃氣上逆證,目前已獲得藥監局批準的臨牀試驗通知書,正在開展作用機制研究和二期臨牀研究;化藥創新藥方面:公司佈局了用於治療肝癌、乳腺癌等多種腫瘤及中重度流感的4個創新藥項目,目前在持續推進中。同時,公司參股子公司浙江特瑞思藥業股份有限公司在研的用於治療復發或難治的B細胞非霍奇金淋巴瘤的核心品種TRS005,已獲得CDE關鍵單臂註冊二期臨牀試驗通知書,目前正在全面推進關鍵註冊二期臨牀試驗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account